ClinicalTrials.govpublic full text
Ertugliflozin: Cardioprotective Effects on Epicardial Fat
cardiovascular diseases, atherosclerosis, type 2 diabetes, insulin resistance, epicardial adipose tissue, sglt2 inhibitor, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 904730
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.